title: Evaluation of Carmeda bioactive surface (CBAS), Duraflo II and a novel nonspecific protease-modified surface using a new in vitro model simulating cardiopulmonary bypass.
authors.affiliation: Department of Cardiothoracic Surgery, Hammersmith Hospital, London.
authors.forename: M
authors.initials: M
authors.lastname: Yii
authors.forename: T
authors.initials: T
authors.lastname: Gourlay
authors.forename: J
authors.initials: J
authors.lastname: Fleming
authors.forename: B
authors.initials: B
authors.lastname: Matata
authors.forename: K M
authors.initials: KM
authors.lastname: Taylor
mesh_terms: D001672:Biocompatible Materials / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass; D015926:Complement C3a / Q000032:analysis; D006801:Humans; D008855:Microscopy, Electron, Scanning; D009504:Neutrophils / Q000502:physiology; D010976:Platelet Count
chemical_list: D001672:Biocompatible Materials; D015926:Complement C3a